Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient

Transplant Infectious Disease

Volumn 9, Issue 3, 2007, Pages 241-243

  Tong, S Y C ^a,d   Peleg, A Y ^a,c   Yoong, J ^a   Handke, R ^b   Szer, J ^a   Slavin, M ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

Antifungal prophylaxis; Fungal infection; Scedosporium sp.

Indexed keywords

AMPHOTERICIN B; AMSACRINE; CASPOFUNGIN; CYCLOPHOSPHAMIDE; CYTARABINE; FLUCONAZOLE; FLUCYTOSINE; FLUDARABINE; ITRACONAZOLE; KETOCONAZOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS; TERBINAFINE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG POTENTIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFECTION PREVENTION; MALE; MYCOSIS; PRIORITY JOURNAL; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; DRUG SYNERGISM; GRAFT VS HOST DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; MADUROMYCOSIS; MALE; MIDDLE AGED; NAPHTHALENES; PYRIMIDINES; SCEDOSPORIUM; STEM CELL TRANSPLANTATION; TRIAZOLES;

EID: 34547782213     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2007.00203.x     Document Type: Article

References (16)

1. Imhof A, Baljee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004 39: 743 746.
2. Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. N Engl J Med 2004 350: 950 952.
3. Cudillo L, Girmenia C, Santilli S, et al. Breakthrough Fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis. Clin Infect Dis 2005 40: 1212 1213.
4. Pavie J, Lacroix C, Hermoso DG, et al. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. J Clin Microbiol 2005 43: 4902 4904.
5. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium forming filamentous fungi. Proposed standard M38-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
6. Hinder J. Clinical Microbiology Procedures Handbook. Vol. 1. Washington DC: ASM, 1992.
7. Meletiadis J, Mouton JW, Meis JFGM, Verweij PE. In vitro drug interaction modelling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 2003 47: 106 117.
8. Capilla J, Yustes C, Mayayo E, et al. Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits. Antimicrob Agents Chemother 2003 47: 1948 1951.
9. Carrillo AJ, Guarro J. In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother 2001 45: 2151 2153.
10. Meletiadis J, Mouton JW, Meis JFGM, Verweij PE. Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificans. Clin Microbiol Infect 2000 6: 336 337.
11. Tamm M, Malouf M, Glanville A. Pulmonary Scedosporium infection following lung transplantation. Transpl Infect Dis 2001 3: 189 194.
12. Jabado N, Casanova J-L, Haddad E, et al. Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin Infect Dis 1998 27: 1437 1441.
13. Oliveira JSR, Kerbauy FR, Colombo AL, et al. Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole. Braz J Med Biol Res 2002 35: 789 793.
14. Husain S, Munoz P, Forrest G, et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005 40: 89 99.
15. Breit SM, Hariprasad SM, Mieler WF, et al. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol 2005 139: 135 140.
16. Kramer M, Kramer MR, Blau H, et al. Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis. Ophthalmology 2006 113: 1184 1186.